Statistics for Aura Biosciences, (id:6616 AURA)

Valuation metrics

Market cap

512.43M

Enterprise value

357.73M

Trailing P/E (ttm)

-4.64

Forward P/E

-5.09

PEG ratio

-5.09

Price/Sales (ttm)

Price/Book (mrq)

2.94

Enterprise Value/Revenue

Enterprise Value/EBITDA

-3.90

Overview

Shares outstanding

49.61M

Float

34.16M

Shares short

1.13M

% Held by insiders

0.05%

% Held by institutions

0.81%

Average volume (10 days)

159.44K

Average volume (90 days)

Price summary

52-Week low

6.63

52-Week high

12.38

52-Week change

10.73%

Beta

0.33

50-Day moving average

9.69

200-Day moving average

8.36

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-30.22%

Return on equity

-50.99%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-91,836,000.00

Net income to common (ttm)

-83,216,000.00

Diluted EPS (ttm)

-1.74

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

174.38M

Total cash per share (mrq)

3.51

Total debt (mrq)

19.08M

Total Debt/Equity (mrq)

10.93

Current ratio (mrq)

1.25K%

Book value per share (mrq)

3.52

Cash flow

Cash flow statement

-73,240,000.00

Levered free cash flow (LFCF)

-49,968,500.00